These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

438 related articles for article (PubMed ID: 37256177)

  • 1. Orchestral role of lipid metabolic reprogramming in T-cell malignancy.
    Mehta A; Ratre YK; Soni VK; Shukla D; Sonkar SC; Kumar A; Vishvakarma NK
    Front Oncol; 2023; 13():1122789. PubMed ID: 37256177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leveraging altered lipid metabolism in treating B cell malignancies.
    Lee J; Mani A; Shin MJ; Krauss RM
    Prog Lipid Res; 2024 Jul; 95():101288. PubMed ID: 38964473
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Stüve P; Minarrieta L; Erdmann H; Arnold-Schrauf C; Swallow M; Guderian M; Krull F; Hölscher A; Ghorbani P; Behrends J; Abraham WR; Hölscher C; Sparwasser TD; Berod L
    Front Immunol; 2018; 9():495. PubMed ID: 29675017
    [No Abstract]   [Full Text] [Related]  

  • 4. Adiponectin triggers breast cancer cell death via fatty acid metabolic reprogramming.
    Pham DV; Park PH
    J Exp Clin Cancer Res; 2022 Jan; 41(1):9. PubMed ID: 34986886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reprogramming lipid metabolism as potential strategy for hematological malignancy therapy.
    Zhang L; Chang N; Liu J; Liu Z; Wu Y; Sui L; Chen W
    Front Oncol; 2022; 12():987499. PubMed ID: 36106108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid droplets as metabolic determinants for stemness and chemoresistance in cancer.
    Royo-García A; Courtois S; Parejo-Alonso B; Espiau-Romera P; Sancho P
    World J Stem Cells; 2021 Sep; 13(9):1307-1317. PubMed ID: 34630864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting lipid reprogramming in the tumor microenvironment by traditional Chinese medicines as a potential cancer treatment.
    Zuo Q; Wu Y; Hu Y; Shao C; Liang Y; Chen L; Guo Q; Huang P; Chen Q
    Heliyon; 2024 May; 10(9):e30807. PubMed ID: 38765144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid raft-mediated Fas/CD95 apoptotic signaling in leukemic cells and normal leukocytes and therapeutic implications.
    Gajate C; Mollinedo F
    J Leukoc Biol; 2015 Nov; 98(5):739-59. PubMed ID: 26246489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aberrant Lipid Metabolism in Cancer: Current Status and Emerging Therapeutic Perspectives.
    Irshad R; Tabassum S; Husain M
    Curr Top Med Chem; 2023; 23(12):1090-1103. PubMed ID: 37218199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty acid oxidation: An emerging facet of metabolic transformation in cancer.
    Ma Y; Temkin SM; Hawkridge AM; Guo C; Wang W; Wang XY; Fang X
    Cancer Lett; 2018 Oct; 435():92-100. PubMed ID: 30102953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polyunsaturated eicosapentaenoic acid changes lipid composition in lipid rafts.
    Li Q; Tan L; Wang C; Li N; Li Y; Xu G; Li J
    Eur J Nutr; 2006 Mar; 45(3):144-51. PubMed ID: 16133744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid metabolism in cancer progression and therapeutic strategies.
    Fu Y; Zou T; Shen X; Nelson PJ; Li J; Wu C; Yang J; Zheng Y; Bruns C; Zhao Y; Qin L; Dong Q
    MedComm (2020); 2021 Mar; 2(1):27-59. PubMed ID: 34766135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting lipid metabolism of cancer cells: A promising therapeutic strategy for cancer.
    Liu Q; Luo Q; Halim A; Song G
    Cancer Lett; 2017 Aug; 401():39-45. PubMed ID: 28527945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipid metabolic Reprogramming: Role in Melanoma Progression and Therapeutic Perspectives.
    Pellerin L; Carrié L; Dufau C; Nieto L; Ségui B; Levade T; Riond J; Andrieu-Abadie N
    Cancers (Basel); 2020 Oct; 12(11):. PubMed ID: 33121001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARα at the crossroad of metabolic-immune regulation in cancer.
    Zeng W; Yin X; Jiang Y; Jin L; Liang W
    FEBS J; 2022 Dec; 289(24):7726-7739. PubMed ID: 34480827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Not too fat to fight: The emerging role of macrophage fatty acid metabolism in immunity to Mycobacterium tuberculosis.
    Laval T; Chaumont L; Demangel C
    Immunol Rev; 2021 May; 301(1):84-97. PubMed ID: 33559209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipid metabolism reprogramming and its potential targets in cancer.
    Cheng C; Geng F; Cheng X; Guo D
    Cancer Commun (Lond); 2018 May; 38(1):27. PubMed ID: 29784041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fatty acid synthase is a metabolic oncogene targetable in malignant peripheral nerve sheath tumors.
    Patel AV; Johansson G; Colbert MC; Dasgupta B; Ratner N
    Neuro Oncol; 2015 Dec; 17(12):1599-608. PubMed ID: 26116612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid Metabolism in Cancer Cells.
    Zheng M; Wang W; Liu J; Zhang X; Zhang R
    Adv Exp Med Biol; 2021; 1316():49-69. PubMed ID: 33740243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid rafts as major platforms for signaling regulation in cancer.
    Mollinedo F; Gajate C
    Adv Biol Regul; 2015 Jan; 57():130-46. PubMed ID: 25465296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.